Vitex doniana Leaves Extract Ameliorates Alterations Associated with 7, 12-Dimethyl Benz[a]Anthracene-Induced Mammary Damage in Female Wistar Rats

References

• Babita KN, Singh M, Malik JS, Kalhan M. Breastfeeding reduces breast cancer risk: a case-control study in North India. Int J Prev Med. 2014;5(6):791–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25013701
   PubMedGoogle Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29313949
   PubMed Web of Science ®Google Scholar
• Rivera-Franco MM, Leon-Rodriguez E. Delays in breast cancer detection and treatment in developing countries. Breast Cancer (Auckl). 2018;12. doi:10.1177/1178223417752677
   PubMed Web of Science ®Google Scholar
• Azubuike SO, Muirhead C, Hayes L, McNally R. Rising global burden of breast cancer: the case of sub-Saharan Africa (with emphasis on Nigeria) and implications for regional development: a review. World J Surg Oncol. 2018;16(1):63. doi:10.1186/s12957-018-1345-2
   PubMed Web of Science ®Google Scholar
• Pace LE, Shulman LN. Breast cancer in Sub-Saharan Africa: Challenges and opportunities to reduce mortality. Oncologist. 2016;21(6):739–44. doi:10.1634/theoncologist.2015-0429
   PubMed Web of Science ®Google Scholar
• Yip CH, Buccimazza I, Hartman M, Deo SVS, Cheung P. Improving outcomes in breast cancer for low and middle income countries. World J Surg. 2015;39(3):686–92. Available from: http://link.springer.com/
   PubMed Web of Science ®Google Scholar
• Nurgali K, Jagoe RT, Abalo R. Editorial: Adverse effects of cancer chemotherapy: Anything new to improve tolerance and reduce sequelae? Front Pharmacol. 2018;9:245. doi:10.3389/fphar.2018.00245
   PubMed Web of Science ®Google Scholar
• Alvarado A, Lopes AC, Faustino-Rocha AI, Cabrita AMS, Ferreira R, Oliveira PA, Colaço B. Prognostic factors in MNU and DMBA-induced mammary tumors in female rats. Pathol - Res Pract. 2017;213(5):441–6. doi:10.1016/j.prp.2017.02.014
   PubMed Web of Science ®Google Scholar
• Ananda H, Sharath Kumar KS, Sudhanva MS, Rangappa S, Rangappa KS. A trisubstituted pyrazole derivative reduces DMBA-induced mammary tumor growth in rats by inhibiting estrogen receptor-α expression. Mol Cell Biochem. 2018;449(1–2):137–44. doi:10.1007/s11010-018-3350-8
   PubMed Web of Science ®Google Scholar
• Kumar A, Sunita P, Jha S, Pattanayak SP. 7,8-Dihydroxycoumarin exerts antitumor potential on DMBA-induced mammary carcinogenesis by inhibiting ERα, PR, EGFR, and IGF1R: involvement of MAPK1/2-JNK1/2-Akt pathway. J Physiol Biochem. 2018;74(2):223–34. doi:10.1007/s13105-018-0608-2
   PubMed Web of Science ®Google Scholar
• Tabaczar S, Domeradzka K, Czepas J, Piasecka-Zelga J, Stetkiewicz J, Gwoździński K, Koceva-Chyła A. Anti-tumor potential of nitroxyl derivative Pirolin in the DMBA-induced rat mammary carcinoma model: A comparison with quercetin. Pharmacol Reports. 2015;67(3):527–34. doi:10.1016/j.pharep.2014.12.010
   PubMed Web of Science ®Google Scholar
• Karnam KC, Ellutla M, Bodduluru LN, Kasala ER, Uppulapu SK, Kalyankumarraju M, Lahkar M. Preventive effect of berberine against DMBA-induced breast cancer in female Sprague Dawley rats. Biomed Pharmacother. 2017;92:207–14. doi:10.1016/j.biopha.2017.05.069
   PubMed Web of Science ®Google Scholar
• Calaf GM, Urzua U, Termini L, Aguayo F. Oxidative stress in female cancers. Oncotarget. 2018;9(34):23824–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29805775
   PubMedGoogle Scholar
• Kumari S, Badana AK, Mohan MG, Shailender G, Malla R. Reactive oxygen species: A key constituent in cancer survival. Biomark Insights. 2018;13.. doi:10.1177/1177271918755391
   PubMed Web of Science ®Google Scholar
• Krishnamachary B, Stasinopoulos I, Kakkad S, Penet M-F, Jacob D, Wildes F, Mironchik Y, Pathak AP, Solaiyappan M, Bhujwalla ZM. Breast cancer cell cyclooxygenase-2 expression alters extracellular matrix structure and function and numbers of cancer associated fibroblasts. Oncotarget. 2017;8(11):17981–94. doi:10.18632/oncotarget.14912
   PubMedGoogle Scholar
• Levitsky DO, Dembitsky VM. Anti-breast cancer agents derived from plants. Nat Products Bioprospect. 2014;5(1):1. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25466288
   PubMed Web of Science ®Google Scholar
• Shagufta AI. Tamoxifen a pioneering drug: An update on the therapeutic potential of tamoxifen derivatives. Eur J Med Chem. 2018;143:515–31. doi:10.1016/j.ejmech.2017.11.056
   PubMed Web of Science ®Google Scholar
• Amegbor K, Metowogo K, Eklu-Gadegbeku K, Agbonon A, Aklikokou KA. Preliminary evaluation of the wound healing effect of Vitex doniana sweet (Verbenaceae) in mice. African J Tradit Complement Altern Med AJTCAM. 2012;9(4):584–90.
   PubMedGoogle Scholar
• Rani A, Sharma A. The genus Vitex: A review. Pharmacogn Rev. 2013;7(14):188–98. doi:10.4103/0973-7847.120522
   PubMedGoogle Scholar
• Agbafor KN, Nwachukwu N. Phytochemical analysis and antioxidant property of leaf extracts of Vitex doniana and Mucuna pruriens. Biochem Res Int. 2011;2011:1–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21547085
   Google Scholar
• Bolanle JD, Adetoro KO, Balarabe SA, Adeyemi OO. Hepatocurative potential of Vitex doniana root bark, stem bark and leaves extracts against CCl4–induced liver damage in rats. Asian Pac J Trop Biomed. 2014;4(6):480–5. doi:10.12980/APJTB.4.2014C207
   PubMedGoogle Scholar
• Iwueke AV, Nwodo OF, Okoli CO. Evaluation of the anti-inflammatory and analgesic activities of Vitex doniana leaves. African J Biotechnol. 2006;5(20):1929–35.
   Google Scholar
• Sahin K, Tuzcu M, Sahin N, Akdemir F, Ozercan I, Bayraktar S, Kucuk O. Inhibitory effects of combination of lycopene and genistein on 7,12- Dimethyl Benz(a)anthracene-induced breast cancer in rats. Nutr Cancer. 2011;63(8):1279–86. doi:10.1080/01635581.2011.606955
   PubMed Web of Science ®Google Scholar
• Niehaus WG, Samuelsson B. Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem. 1968;6(1):126–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/4387188
   PubMedGoogle Scholar
• Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70–7. Available from: https://www.sciencedirect.com/science/article/abs/pii/0003986159900906
   PubMed Web of Science ®Google Scholar
• Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972;247(10):3170–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/4623845
   PubMed Web of Science ®Google Scholar
• Sinha AK. Colorimetric assay of catalase. Anal Biochem. 1972;47(2):389–94. Available from: https://www.sciencedirect.com/science/article/pii/0003269772901327
   PubMed Web of Science ®Google Scholar
• Fischer AH, Jacobson KA, Rose J, Zeller R. Hematoxylin and eosin staining of tissue and cell sections. Cold Spring Harb Protoc. 2008;2008(6):pdb.prot4986–pdb.prot4986. doi:10.1101/pdb.prot4986
   Google Scholar
• Costa I, Solanas M, Escrich E. Histopathologic characterization of mammary neoplastic lesions induced with 7,12 dimethylbenz(alpha)anthracene in the rat: a comparative analysis with human breast tumors. Arch Pathol Lab Med. 2002;126(8):915–27. doi:10.1043/0003-9985(2002)126<0915:HCOMNL>2.0.CO;2
   PubMed Web of Science ®Google Scholar
• Louie MC, Sevigny MB. Steroid hormone receptors as prognostic markers in breast cancer. Am J Cancer Res. 2017;7(8):1617–36. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28861319
   PubMed Web of Science ®Google Scholar
• Yaşar P, Ayaz G, User SD, Güpür G, Muyan M. Molecular mechanism of estrogen-estrogen receptor signaling. Reprod Med Biol. 2017;16(1):4–20. doi:10.1002/rmb2.12006
   PubMed Web of Science ®Google Scholar
• Bishayee A, Mandal A, Thoppil RJ, Darvesh AS, Bhatia D. Chemopreventive effect of a novel oleanane triterpenoid in a chemically induced rodent model of breast cancer. Int J Cancer. 2013;133(5):1054–63. doi:10.1002/ijc.28108
   PubMed Web of Science ®Google Scholar
• Ali S, School of life science, Jawaharlal Nehru University, New Delhi, India, Rasool M, Chaoudhry H, Pushparaj PN, Jha P, Hafiz A, Mahfooz M, Sami GA, Kamal MA, Bashir S, et al. Molecular mechanisms and mode of tamoxifen resistance in breast cancer. Bioinformation. 2016;12(3):135–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28149048
   PubMed Web of Science ®Google Scholar
• Hecht F, Pessoa CF, Gentile LB, Rosenthal D, Carvalho DP, Fortunato RS. The role of oxidative stress on breast cancer development and therapy. Tumor Biol. 2016;37(4):4281–91. Available from: http://link.springer.com/
   PubMedGoogle Scholar
• Kalaiselvi M, Gomathi D, Ravikumar G, Devaki K, Uma C. Ameliorative effect of Ananus comosus peel on 7, 12 dimethylbenz (毩) anthracene induced mammary carcinogenesis with reference to oxidative stress. J Acute Dis. 2013;2:22–8. doi:10.1016/S2221-6189(13)60089-X
   Google Scholar
• Adetoro KO, Bolanle JD, Abdullahi SB, Ahmed OA. In vivo antioxidant effect of aqueous root bark, stem bark and leaves extracts of Vitex doniana in CCl4 induced liver damage rats. Asian Pac J Trop Biomed. 2013;3(5):395–400. doi:10.1016/S2221-1691(13)60083-0
   PubMedGoogle Scholar
• Glorieux C, Calderon PB. Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach. Biol Chem. 2017;398(10):1095–108. doi:10.1515/hsz-2017-0131
   PubMed Web of Science ®Google Scholar
• Glorieux C, Auquier J, Dejeans N, Sid B, Demoulin J-B, Bertrand L, Verrax J, Calderon PB. Catalase expression in MCF-7 breast cancer cells is mainly controlled by PI3K/Akt/mTor signaling pathway. Biochem Pharmacol. 2014;89(2):217–23. doi:10.1016/j.bcp.2014.02.025
   PubMed Web of Science ®Google Scholar
• Simone-Reuter BBA. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic Biol Med. 2011;49(11):1603–16. doi:10.1016/j.freeradbiomed.2010.09.006
   Web of Science ®Google Scholar
• Silva FB, Romero WG, Carvalho A. L R d A, Souza GAA, Claudio ERG, Abreu GR. Effects of treatment with chemotherapy and/or tamoxifen on the biomarkers of cardiac injury and oxidative stress in women with breast cancer. Medicine (Baltimore). 2017;96(47):e8723. doi:10.1097/MD.0000000000008723
   PubMed Web of Science ®Google Scholar
• Tulotta C, Ottewell P. The role of IL-1B in breast cancer bone metastasis. Endocr Relat Cancer. 2018;25(7):R421–34. doi:10.1530/ERC-17-0309
   PubMed Web of Science ®Google Scholar
• Kamel M, Shouman S, El-Merzebany M, Kilic G, Veenstra T, Saeed M, Wagih M, Diaz-Arrastia C, Patel D, Salama S, et al. Effect of tumour necrosis factor-alpha on estrogen metabolic pathways in breast cancer cells. J Cancer. 2012;3:310–21. doi:10.7150/jca.4584
   PubMed Web of Science ®Google Scholar
• Baumgarten SC, Frasor J. Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers. Mol Endocrinol. 2012;26(3):360–71. doi:10.1210/me.2011-1302
   PubMedGoogle Scholar
• Cho H, Park JH, Ahn EK, Oh JS. Kobophenol A isolated from roots of caragana sinica (Buc’hoz) Rehder exhibits anti-inflammatory activity by regulating NF-κB nuclear translocation in J774A.1 Cells. Toxicol Reports. 2018;5:647–53. doi:10.1016/j.toxrep.2018.05.011
   PubMed Web of Science ®Google Scholar
• Wen HC, Aguirre-Ghiso JA. Stress signaling and the shaping of the mammary tissue in development and cancer. Oncogene. 2014;33:1–8. Available from: doi:10.1038/onc.2013.554
   PubMed Web of Science ®Google Scholar
• Ercan C, van Diest PJ, Vooijs M. Mammary development and breast cancer: the role of stem cells. CMM. 2011;11(4):270–85. doi:10.2174/156652411795678007
   PubMed Web of Science ®Google Scholar
• Mohammed ZM, Going JJ, Edwards J, Elsberger B, Doughty JC, McMillan DC. The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer. Br J Cancer. 2012;107(5):864–73. doi:10.1038/bjc.2012.347
   PubMed Web of Science ®Google Scholar
• Hartmann LC, Degnim AC, Santen RJ, Dupont WD, Ghosh K. Atypical hyperplasia of the breast–risk assessment and management options. N Engl J Med. 2015;372(1):78–89. doi:10.1056/NEJMsr1407164
   PubMed Web of Science ®Google Scholar
• Cole K, Tabernero M, Anderson KS. Biologic characteristics of premalignant breast disease. Cancer Biomark. 2010;9(1–6):177–92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22112476.
   PubMed Web of Science ®Google Scholar
• Shaaban AM, Sloane JP, West CR, Foster CS. Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-alpha and Ki-67 expression. Am J Pathol. 2002;160(2):597–604. doi:10.1016/S0002-9440(10)64879-1
   PubMed Web of Science ®Google Scholar
• Dykes SS, Hughes VS, Wiggins JM, Fasanya HO, Tanaka M, Siemann D. Stromal cells in breast cancer as a potential therapeutic target. Oncotarget. 2018;9(34):23761–79. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29805773
   PubMedGoogle Scholar
• Jana D, Sarkar DK, Ganguly S, Saha S, Sa G, Manna AK, Banerjee A, Mandal S. Role of Cyclooxygenase 2 (COX-2) in Prognosis of Breast Cancer. Indian J Surg Oncol. 2014;5(1):59–65. doi:10.1007/s13193-014-0290-y
   PubMedGoogle Scholar
• Subbaramaiah K, Norton L, Gerald W, Dannenberg AJ. Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3. J Biol Chem. 2002;277(21):18649–57. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11901151
   PubMed Web of Science ®Google Scholar
• Harris RE, Casto BC, Harris ZM. Cyclooxygenase-2 and the inflammogenesis of breast cancer. World J Clin Oncol. 2014;5(4):677. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25302170
   PubMedGoogle Scholar
• Davies G, Martin L-A, Sacks N, Dowsett M. Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention. Ann Oncol. 2002;13(5):669–78. doi:10.1093/annonc/mdf125
   PubMed Web of Science ®Google Scholar
• Catarino MD, Alves-Silva JM, Pereira OR, Cardoso SM. Antioxidant capacities of flavones and benefits in oxidative-stress related diseases. CTMC. 2015;15(2):105–19. doi:10.2174/1568026615666141209144506
   Web of Science ®Google Scholar
• Mani R, Natesan V. Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action. Phytochemistry. 2018;145:187–96. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29161583
   PubMed Web of Science ®Google Scholar
• Wang J, Wang H, Sun K, Wang X, Pan H, Zhu J, Ji X, Li X. Chrysin suppresses proliferation, migration, and invasion in glioblastoma cell lines via mediating the ERK/Nrf2 signaling pathway. Drug Des Devel Ther. 2018;12:721–33. doi:10.2147/DDDT.S160020
   PubMed Web of Science ®Google Scholar
• Nile SH, Keum YS, Nile AS, Jalde SS, Patel RV. Antioxidant, anti-inflammatory, and enzyme inhibitory activity of natural plant flavonoids and their synthesized derivatives. J Biochem Mol Toxicol. 2018;32(1):e22002. doi:10.1002/jbt.22002
   Web of Science ®Google Scholar
• DeBolt S, Cook DR, Ford CM. L-Tartaric acid synthesis from vitamin C in higher plants. Proc Natl Acad Sci. 2006;103(14):5608–13. doi:10.1073/pnas.0510864103
   PubMed Web of Science ®Google Scholar
• Melino VJ, Soole KL, Ford CM. Ascorbate metabolism and the developmental demand for tartaric and oxalic acids in ripening grape berries. BMC Plant Biol. 2009;9(1):145. doi:10.1186/1471-2229-9-145
   PubMed Web of Science ®Google Scholar
• Weber N, Ismail A, Gorwa-Grauslund M, Carlquist M. Biocatalytic potential of vanillin aminotransferase from Capsicum chinense. BMC Biotechnol. 2014;14(1):25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24712445
   PubMed Web of Science ®Google Scholar
• Chapa-Oliver A, Mejía-Teniente L. Capsaicin: From plants to a cancer-suppressing agent. Molecules. 2016;21(8):931. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27472308
   PubMed Web of Science ®Google Scholar
• Clark R, Lee SH. Anticancer properties of Capsaicin against human cancer. Anticancer Res. 2016;36(3):837–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26976969
   PubMed Web of Science ®Google Scholar